BrainXell today announced the launch of its human induced pluripotent stem cell (iPSC)-derived sensory neurons, a scalable human cellular platform engineered to support reproducible functional studies ...
A Japanese health ministry panel has endorsed two products using iPS cells, paving the way for the world's first practical ...
In February 2026, XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for Phase I/II registrational clinical trial entry with its ...
VANCOUVER, BC and TOKYO, March 3, 2026 /CNW/ - The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the ...
bit.bio's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference, and it was chosen from over 10,500+ submissions. bit.bio will host an expert panel ...
Japanese government experts endorsed on Thursday ground-breaking projects to manufacture regenerative medicine products to ...
DALLAS--(BUSINESS WIRE)--Colossal Biosciences (“Colossal”), the world’s first de-extinction company, announces today that their Woolly Mammoth team has achieved a global-first iPSC (induced ...
Human induced pluripotent stem cell (iPSC) technology has enabled the generation of virtually any human cell type from somatic cells obtained from healthy or disease donors. This powerful platform has ...
The iPSC-derived NK cells clinical trial analysis report delivers important insights into ongoing research of 15+ pipeline iPSC-derived NK cells drugs, clinical strategies, upcoming therapeutics, and ...
Three lines of GMP iPS Cells derived from type O female blood are now offered as off-the-shelf product It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results